GB8903804D0 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number: GB8903804D0
Authority: GB; United Kingdom
Prior art keywords: relating; organic compounds; compounds; organic
Prior art date: 1989-02-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

Family has litigation

First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=10651981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB8903804(D0)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1989-02-20Priority to GB898903804ApriorityCriticalpatent/GB8903804D0/en

1989-02-20Application filed by Sandoz AGfiledCriticalSandoz AG

1989-04-05Publication of GB8903804D0publicationCriticalpatent/GB8903804D0/en

1990-02-16Priority to CH504/90Aprioritypatent/CH680650A5/de

1990-02-16Priority to GB9003616Aprioritypatent/GB2228198B/en

1990-02-19Priority to FR9002086Aprioritypatent/FR2643262B1/en

1990-02-19Priority to BE9000181Aprioritypatent/BE1005236A3/en

1990-02-19Priority to JP2038168Aprioritypatent/JPH0611703B2/en

1990-02-19Priority to DE4005190Aprioritypatent/DE4005190A1/en

1990-02-20Priority to IT47650Aprioritypatent/IT1240765B/en

1993-12-06Priority to US08/163,193prioritypatent/US5639724A/en

1995-06-06Priority to US08/471,302prioritypatent/US5652212A/en

1995-06-06Priority to US08/471,301prioritypatent/US5759997A/en

1995-09-21Priority to HK149595Aprioritypatent/HK149595A/en

1995-12-31Priority to SA95160491Aprioritypatent/SA95160491B1/en

1996-04-05Priority to CY188696Aprioritypatent/CY1886A/en

1998-03-24Priority to US09/047,056prioritypatent/US5977066A/en

2000-04-19Priority to US09/552,634prioritypatent/US6306825B1/en

2001-08-16Priority to US09/931,680prioritypatent/US6468968B2/en

2002-09-04Priority to US10/234,273prioritypatent/US20030060402A1/en

2004-03-01Priority to US10/790,543prioritypatent/US7081445B2/en

2006-06-15Priority to US11/453,504prioritypatent/US7511014B2/en

StatusPendinglegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB898903804A1984-07-241989-02-20Improvements in or relating to organic compoundsPendingGB8903804D0 (en)

Priority Applications (20)

Application Number	Priority Date	Filing Date	Title
GB898903804AGB8903804D0 (en)	1989-02-20	1989-02-20	Improvements in or relating to organic compounds
CH504/90ACH680650A5 (en)	1989-02-20	1990-02-16
GB9003616AGB2228198B (en)	1989-02-20	1990-02-16	Novel cyclosporin galenic forms
DE4005190ADE4005190A1 (en)	1989-02-20	1990-02-19	NEW CYCLOSPORINE GALENIC FORMS
JP2038168AJPH0611703B2 (en)	1989-02-20	1990-02-19	New cyclosporin formulation
FR9002086AFR2643262B1 (en)	1989-02-20	1990-02-19	PHARMACEUTICAL COMPOSITIONS BASED ON CYCLOSPORINS
BE9000181ABE1005236A3 (en)	1989-02-20	1990-02-19	PHARMACEUTICAL COMPOSITIONS cyclosporin.
IT47650AIT1240765B (en)	1989-02-20	1990-02-20	CYCLOSPORINE PHARMACEUTICAL COMPOSITIONS.
US08/163,193US5639724A (en)	1984-07-24	1993-12-06	Cyclosporin galenic forms
US08/471,302US5652212A (en)	1984-07-24	1995-06-06	Cyclosporin galenic forms
US08/471,301US5759997A (en)	1984-07-24	1995-06-06	Cyclosporin galenic forms
HK149595AHK149595A (en)	1989-02-20	1995-09-21	Novel cyclosporin galenic forms
SA95160491ASA95160491B1 (en)	1989-02-20	1995-12-31	New galenic forms of cyclosporin
CY188696ACY1886A (en)	1989-02-20	1996-04-05	Novel cyclosporin galenic forms
US09/047,056US5977066A (en)	1984-07-24	1998-03-24	Cyclosporin galenic forms
US09/552,634US6306825B1 (en)	1984-07-24	2000-04-19	Cyclosporin galenic forms
US09/931,680US6468968B2 (en)	1984-07-24	2001-08-16	Cyclosporin galenic forms
US10/234,273US20030060402A1 (en)	1984-07-24	2002-09-04	Novel cyclosporin galenic forms
US10/790,543US7081445B2 (en)	1989-02-20	2004-03-01	Cyclosporin galenic forms
US11/453,504US7511014B2 (en)	1989-02-20	2006-06-15	Cyclosporin galenic forms

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898903804AGB8903804D0 (en)	1989-02-20	1989-02-20	Improvements in or relating to organic compounds

Publications (1)

Publication Number	Publication Date
GB8903804D0true GB8903804D0 (en)	1989-04-05

Family

ID=10651981

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB898903804APendingGB8903804D0 (en)	1984-07-24	1989-02-20	Improvements in or relating to organic compounds
GB9003616AExpired - LifetimeGB2228198B (en)	1989-02-20	1990-02-16	Novel cyclosporin galenic forms

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB9003616AExpired - LifetimeGB2228198B (en)	1989-02-20	1990-02-16	Novel cyclosporin galenic forms

Country Status (9)

Country	Link
JP (1)	JPH0611703B2 (en)
BE (1)	BE1005236A3 (en)
CH (1)	CH680650A5 (en)
CY (1)	CY1886A (en)
DE (1)	DE4005190A1 (en)
FR (1)	FR2643262B1 (en)
GB (2)	GB8903804D0 (en)
HK (1)	HK149595A (en)
IT (1)	IT1240765B (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639724A (en)	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
GB8904182D0 (en)*	1989-02-23	1989-04-05	Glaxo Canada	Pharmaceutical compositions
HU208491B (en)*	1990-11-27	1993-11-29	Gyogyszerkutato Intezet	Process for producing oral pharmaceutical composition containing cyclosporin
US6262022B1 (en)	1992-06-25	2001-07-17	Novartis Ag	Pharmaceutical compositions containing cyclosporin as the active agent
AU688920B2 (en)*	1991-06-27	1998-03-19	Novartis Ag	Transesterified corn oil products
GB9113872D0 (en)*	1991-06-27	1991-08-14	Sandoz Ag	Improvements in or relating to organic compounds
IL102236A0 (en)*	1991-06-27	1993-01-14	Ltt Inst Co Ltd	Topical preparations containing cyclosporin
EP0642332B1 (en)	1992-05-13	1997-01-15	Sandoz Ltd.	Ophthalmic compositions containing a cyclosporin
US5759566A (en)*	1992-07-28	1998-06-02	Poli Industria Chimica Spa	Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
DK0589843T3 (en)*	1992-09-25	2002-04-02	Novartis Ag	Cyclosporin-containing pharmaceutical preparations
WO1994023733A1 (en)†	1993-04-20	1994-10-27	Dr. Rentschler Arzneimittel Gmbh & Co.	New cyclosporine-containing pharmaceutical compositions for oral administration
DE4412201A1 (en)*	1993-04-20	1994-11-10	Rentschler Arzneimittel	New pharmaceutical preparations for oral administration containing cyclosporin
NZ247516A (en)*	1993-04-28	1995-02-24	Bernard Charles Sherman	Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4322826A1 (en)*	1993-07-08	1995-01-12	Galenik Labor Freiburg Gmbh	Pharmaceutical preparation
DE4340781C3 (en)*	1993-11-30	2000-01-27	Novartis Ag	Liquid preparations containing cyclosporin and process for their preparation
EP0694308A4 (en)*	1994-02-17	1997-09-10	Shiseido Co Ltd	Cyclosporin-containing emulsion composition
US5891846A (en)*	1994-02-17	1999-04-06	Shiseido Company, Ltd.	Cyclosporin-containing emulsion composition
GB9405304D0 (en)*	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
US5474979A (en)*	1994-05-17	1995-12-12	Allergan, Inc.	Nonirritating emulsions for sensitive tissue
CA2231404C (en)	1994-11-03	2009-02-17	Arzneimittelwerk Dresden Gmbh	Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
US5603951A (en)*	1994-11-09	1997-02-18	Hanmi Pharm. Ind. Co., Ltd.	Cyclosporin-containing soft capsule compositions
KR0167613B1 (en)*	1994-12-28	1999-01-15	한스 루돌프 하우스, 니콜 케르커	Cyclosporine-containing soft capsule composition
US5834017A (en)*	1995-08-25	1998-11-10	Sangstat Medical Corporation	Oral cyclopsporin formulations
US5766629A (en)*	1995-08-25	1998-06-16	Sangstat Medical Corporation	Oral cyclosporin formulations
US5962019A (en)*	1995-08-25	1999-10-05	Sangstat Medical Corporation	Oral cyclosporin formulations
US5827822A (en)*	1996-03-25	1998-10-27	Sangstat Medical Corporation	Cyclosporin a formulations as nanoparticles
DE19544507B4 (en)	1995-11-29	2007-11-15	Novartis Ag	Cyclosporin containing preparations
CZ288631B6 (en)*	1996-01-18	2001-08-15	Galena, A. S.	Therapeutic preparations containing cyclosporin
US5858401A (en)	1996-01-22	1999-01-12	Sidmak Laboratories, Inc.	Pharmaceutical composition for cyclosporines
GB2335854B (en)	1997-01-30	2001-04-25	Novartis Ag	Oil-free pharmaceutical compositions containing cyclosporin A
CA2284000C (en)*	1997-03-12	2012-01-03	Abbott Laboratories	Hydrophilic binary systems for the administration of cyclosporine
EP0973502A1 (en)*	1997-03-12	2000-01-26	Abbott Laboratories	Lipophilic binary systems for the administration of lipophilic compounds
AU728626B2 (en)	1997-07-29	2001-01-11	Pharmacia & Upjohn Company	Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
HU225160B1 (en)*	1997-07-29	2006-07-28	Upjohn Co	Self-emulsifying formulation for lipophilic compounds
US6346511B1 (en)	1997-09-08	2002-02-12	Panacea Biotec Limited	Pharmaceutical composition comprising cyclosporin
US6008191A (en)*	1997-09-08	1999-12-28	Panacea Biotec Limited	Pharmaceutical compositions containing cyclosporin
US6187747B1 (en)	1997-09-08	2001-02-13	Panacea Biotech Limited	Pharmaceutical composition comprising cyclosporin
US5981607A (en)*	1998-01-20	1999-11-09	Allergan	Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
ID25908A (en)*	1998-03-06	2000-11-09	Novartis Ag	EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES
DE19859910C2 (en)*	1998-12-23	2001-03-22	Ratiopharm Gmbh	Oral medicine
US6248363B1 (en)*	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9912476D0 (en)	1999-05-28	1999-07-28	Novartis Ag	Organic compounds
GB2362573A (en)*	2000-05-25	2001-11-28	Cipla Ltd	Cyclosporin formulation
AU2127400A (en)*	1999-11-02	2001-05-14	Cipla Limited	A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
DK1151755T3 (en)*	2000-05-04	2005-06-27	Panacea Biotec Ltd	Pharmaceutical preparation containing cyclosporin as active ingredient
DE10030378A1 (en)*	2000-06-21	2002-03-14	Audit Inst For Medical Service	New pharmaceutical composition for topical application of water-insoluble and / or poorly water-soluble active ingredients
AU2002333098B2 (en)	2001-10-19	2006-03-16	Isotechnika Pharma Inc.	Novel cyclosporin analog microemulsion preconcentrates
US6979672B2 (en)	2002-12-20	2005-12-27	Polichem, S.A.	Cyclosporin-based pharmaceutical compositions
JP4381037B2 (en)	2003-06-04	2009-12-09	花王株式会社	Oil composition
US8673351B2 (en)	2005-03-21	2014-03-18	Ivax Pharmaceuticals S.R.O.	Crystallization inhibitor and its use in gelatin capsules
US8492369B2 (en)	2010-04-12	2013-07-23	Clarus Therapeutics Inc	Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
BRPI0607549A2 (en)	2005-04-15	2009-09-15	Clarus Therapeutics Inc	pharmaceutical delivery systems for hydrophobic drugs and compositions comprising the same
FR2914188B1 (en)*	2007-03-28	2012-06-22	Trophos	NEW CHOLEST-4-EN-3-ONE OXIME COMPOSITION
GB2451811A (en)	2007-08-09	2009-02-18	Ems Sa	Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
CA2690490C (en)*	2010-01-19	2012-06-26	Accucaps Industries Limited	Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
EP3095453B1 (en)*	2014-01-16	2023-03-01	Maruho Co., Ltd.	Topical agent for transdermal administration
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en)	2014-08-28	2017-08-31	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (en)	2016-11-28	2018-05-31	Nachiappan Chidambaram	Oral testosterone undecanoate therapy
AU2019308326A1 (en)	2018-07-20	2021-03-18	Lipocine Inc.	Liver disease
SG11202111251SA (en)	2019-04-11	2021-11-29	R P Scherer Technologies Llc	Formulation for oral delivery of proteins, peptides and small molecules with poor permeability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI65914C (en)*	1978-03-07	1984-08-10	Sandoz Ag	FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
CH641356A5 (en)*	1979-02-27	1984-02-29	Sandoz Ag	Pharmaceutical compositions containing cyclosporin
AU558155B2 (en)*	1982-02-01	1987-01-22	Sandoz Ltd.	Treating multiple sclerosis with dihydro-cyclosporin d

1989
- 1989-02-20GBGB898903804Apatent/GB8903804D0/enactivePending
1990
- 1990-02-16GBGB9003616Apatent/GB2228198B/ennot_activeExpired - Lifetime
- 1990-02-16CHCH504/90Apatent/CH680650A5/denot_activeIP Right Cessation
- 1990-02-19FRFR9002086Apatent/FR2643262B1/ennot_activeExpired - Lifetime
- 1990-02-19DEDE4005190Apatent/DE4005190A1/ennot_activeCeased
- 1990-02-19BEBE9000181Apatent/BE1005236A3/ennot_activeIP Right Cessation
- 1990-02-19JPJP2038168Apatent/JPH0611703B2/ennot_activeExpired - Lifetime
- 1990-02-20ITIT47650Apatent/IT1240765B/enactiveIP Right Grant
1995
- 1995-09-21HKHK149595Apatent/HK149595A/ennot_activeIP Right Cessation
1996
- 1996-04-05CYCY188696Apatent/CY1886A/enunknown

Also Published As

Publication number	Publication date
CH680650A5 (en)	1992-10-15
FR2643262B1 (en)	1993-06-11
FR2643262A1 (en)	1990-08-24
GB9003616D0 (en)	1990-04-11
CY1886A (en)	1996-04-05
IT9047650A0 (en)	1990-02-20
HK149595A (en)	1995-09-29
GB2228198B (en)	1992-12-16
GB2228198A (en)	1990-08-22
DE4005190A1 (en)	1990-08-23
IT1240765B (en)	1993-12-17
BE1005236A3 (en)	1993-06-08
JPH0611703B2 (en)	1994-02-16
JPH02255623A (en)	1990-10-16
IT9047650A1 (en)	1990-08-21

Publication	Publication Date	Title
GB8903804D0 (en)	1989-04-05	Improvements in or relating to organic compounds
AP9000217A0 (en)	1991-01-31	Improvements in or relating to organic compounds
GB8901517D0 (en)	1989-03-15	Improvements in or relating to organic compounds
AP9000207A0 (en)	1990-10-31	Improvements in or relating to organic compounds
GB8905726D0 (en)	1989-04-26	Improvements in or relating to organic compounds
GB8902305D0 (en)	1989-03-22	Improvements in or relating to organic compounds
GB8900246D0 (en)	1989-03-08	Improvements in or relating to organic compounds
GB8900455D0 (en)	1989-03-08	Improvements in or relating to organic compounds
GB8900847D0 (en)	1989-03-08	Improvements in or relating to organic compounds
GB8902154D0 (en)	1989-03-22	Improvements in or relating to organic compounds
GB8902303D0 (en)	1989-03-22	Improvements in or relating to organic compounds
GB8902304D0 (en)	1989-03-22	Improvements in or relating to organic compounds
GB8906363D0 (en)	1989-05-04	Improvements in or relating to organic compounds
GB8902656D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902897D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902898D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902899D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902900D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902901D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902902D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8902903D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8903146D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8903147D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8903149D0 (en)	1989-03-30	Improvements in or relating to organic compounds
GB8903150D0 (en)	1989-03-30	Improvements in or relating to organic compounds

Movatterモバイル変換